# Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow

> **NCT02757885** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 10 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **PROCEDURE:** Bone Marrow Transplant (BMT)
- **DRUG:** Hydroxyurea
- **DRUG:** Thiotepa
- **DRUG:** Fludarabine monophosphate
- **DRUG:** Cyclophosphamide
- **OTHER:** Rabbit Anti-thymocyte Globulin
- **RADIATION:** Total Body Irradiation

## Key facts

- **NCT ID:** NCT02757885
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-10
- **Primary completion:** 2021-12-12
- **Final completion:** 2021-12-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757885, "Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02757885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*